Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis.

Cardiovascular disease Complication of diabetic Diabetic foot ulcer Iran Nephropathy Neuropathy Prevalence Retinopathy Systematic review and meta-analysis

Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
Historique:
received: 27 04 2019
accepted: 22 05 2019
entrez: 26 6 2019
pubmed: 27 6 2019
medline: 18 12 2019
Statut: ppublish

Résumé

Complications among patients with type 2 diabetes mellitus (T2DM) have increased dramatically through two past decades. Thus, the aim of this updated systematic review and meta-analysis was to estimate the pooled prevalence of T2DM complications in Iranian patients. Using Medical Subject Headings terms, Emtree, and related equal Persian key words, international databases including PubMed, ISI/WOS, Scopus, Iran Medex, SID, Magiran, Irandoc, Medlib, domestic databases were searched from January 1990 till January 2018 reporting prevalence of any complications of type 2 diabetes in Iran. All the keywords were searched electronically by two Boolean operators through the explained search strategy, separately. Relevant additional articles were identified from the lists of the retrieved articles. Random and fixed effect meta-analysis was used to estimate the pooled prevalence of complications in Iranian patients with T2DM. Through searching steps, among 1238 publications retrieved from literature search, finally 45 studies met the inclusion criteria for meta-analysis, with number of 30679 participants. According to random effect, the estimated pooled prevalence of diabetic foot ulcer, cardiovascular disease, retinopathy, neuropathy and nephropathy in Iranian patients with T2DM were 3%(95% CI: 1-5%), 33%(95% CI: 16-49%), 36%(95% CI: 27-45%), 38% (95% CI: 14-63%), and 43% (95% CI: 27-60%), respectively. This updated meta-analysis shows that prevalence of major microvascular complications of T2DM in Iran is high. Our findings provide practical evidence for better planning and clinical decision making.

Identifiants

pubmed: 31235172
pii: S1871-4021(19)30283-8
doi: 10.1016/j.dsx.2019.05.018
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2300-2312

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Yousef Moradi (Y)

Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

Hamid Reza Baradaran (HR)

Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Iran. Electronic address: baradaran.hr@iums.ac.ir.

Shirin Djalalinia (S)

Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ahdieh Chinekesh (A)

Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.

Mohamad Ebrahim Khamseh (ME)

Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.

Maryam Dastoorpoor (M)

Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Amir-Babak Sioofy-Khojine (AB)

Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520, Tampere, Finland.

Lotfolah Saed (L)

Department of Endocrinology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Mostafa Qorbani (M)

Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mqorbani1379@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH